Cargando…
Serum metabolomics differentiating pancreatic cancer from new-onset diabetes
To establish a screening strategy for pancreatic cancer (PC) based on new-onset diabetic mellitus (NO-DM), serum metabolomics analysis and a search for the metabolic pathways associated with PC related DM were performed. Serum samples from patients with NO-DM (n = 30) and patients with pancreatic ca...
Autores principales: | He, Xiangyi, Zhong, Jie, Wang, Shuwei, Zhou, Yufen, Wang, Lei, Zhang, Yongping, Yuan, Yaozong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Impact Journals LLC
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5438717/ https://www.ncbi.nlm.nih.gov/pubmed/28418859 http://dx.doi.org/10.18632/oncotarget.16249 |
Ejemplares similares
-
Knockdown of the DJ-1 (PARK7) gene sensitizes pancreatic cancer to erlotinib inhibition
por: He, Xiangyi, et al.
Publicado: (2021) -
Metabolomics Applied to Cord Serum in Preeclampsia Newborns: Implications for Neonatal Outcomes
por: Wang, Xiaoxu, et al.
Publicado: (2022) -
SiRNA-mediated PIAS1 silencing promotes inflammatory response and leads to
injury of cerulein-stimulated pancreatic acinar cells via regulation of the P38MAPK
signaling pathway
por: Chen, Ping, et al.
Publicado: (2021) -
Pancreatic Cancer Presenting as New-Onset Diabetes
por: Patel, Ruchir, et al.
Publicado: (2014) -
Metabolomics Identifies Biomarker Signatures to Differentiate Pancreatic Cancer from Type 2 Diabetes Mellitus in Early Diagnosis
por: Xu, Hongmin, et al.
Publicado: (2021)